Predictive Factors of Pulmonary Embolism in Older Patients with SARS-CoV-2: The OCTA-COVID-19 Study

被引:2
作者
Quezada-Feijoo, Maribel [1 ,2 ]
Ramos, Monica [1 ,2 ]
Lozano-Montoya, Isabel [2 ,3 ]
Toro, Rocio [4 ,5 ]
Jaramillo-Hidalgo, Javier [2 ,3 ]
Fernandez de la Puente, Eva [3 ]
Garmendia, Blanca [2 ,3 ]
Carrillo, Pamela [2 ,3 ]
Cristofori, Giovanna [3 ]
Goni Roson, Saleta [3 ]
Ayala, Rocio [1 ,2 ]
Sarro, Monica [6 ]
Gomez-Pavon, Francisco J. [2 ,3 ]
机构
[1] Hosp Cent Cruz Roja, Cardiol Dept, C Reina Victoria 24, Madrid 28003, Spain
[2] Alfonso X El Sabio Univ, Sch Med, Avda Univ 1, Madrid 28691, Spain
[3] Hosp Cent Cruz Roja, Geriatr Dept, C Reina Victoria 24, Madrid 28003, Spain
[4] Puerta Mar Univ Hosp, Res Unit, Biomed Res & Innovat Inst Cadiz INiBICA, Av Ana Viya 21, Cadiz 11009, Spain
[5] Cadiz Univ, Sch Med, Med Dept, Edificio Andres Segovia 3 Floor,C Dr Maranon S-N, Cadiz 21001, Spain
[6] Hosp Cent La Cruz Roja, Radiol Dept, C Reina Victoria 24, Madrid 28003, Spain
关键词
pulmonary embolism; older; COVID-19; VENOUS THROMBOEMBOLISM; COVID-19; PATIENTS; D-DIMER; EPIDEMIOLOGY; THROMBOSIS; FRAILTY;
D O I
10.3390/jcm10132998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The risk of pulmonary embolism (PE) has not been studied in older patients affected by COVID-19. We aimed to assess PE incidence and risk factors in a population of older patients infected with SARS-CoV-2. Methods: An ambispective, observational cohort study. A total of 305 patients >= 75 years old had the SARS-CoV-2 infection from March to May 2020. The incidence rate of PE was estimated as the proportion of new cases within the whole sample. Youden's index was used to assess the cutoff point of D-dimer. To select factors associated with the risk of PE, time-to-event analyses were performed using cause-specific hazard models. Results: In total, 305 patients with a median age of 87 years (62.3% female) were studied; 67.9% were referred from nursing homes and 90.4% received any type of anticoagulation. A total of 64.9% showed frailty and 44% presented with dementia. The PE incidence was 5.6%. The cutoff value of a D-dimer level over 2.59 mg/L showed a sensitivity of 82.4% and specificity of 73.8% in discriminating a PE diagnosis. In the multivariate analysis, the factors associated with PE were previous oncological events and D-dimer levels. Conclusions: The PE incidence was 5.6%, and major risk factors for PE were oncological antecedents and increased plasma D-dimer levels.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
    Dao, Thi Loi
    Hoang, Van Thuan
    Colson, Philippe
    Lagier, Jean Christophe
    Million, Matthieu
    Raoult, Didier
    Levasseur, Anthony
    Gautret, Philippe
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [22] Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19
    Fathizadeh, Hadis
    Taghizadeh, Sepehr
    Safari, Rohollah
    Khiabani, Saeid Shabestari
    Babak, Bayaz
    Hamzavi, Fatemeh
    Ganbarov, Khudaverdi
    Esposito, Silvano
    Zeinalzadeh, Elham
    Dao, Sounkalo
    Kose, Sukran
    Kafil, Hossein Samadi
    MICROBIAL PATHOGENESIS, 2020, 149
  • [23] Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
    Yamada, Shinya
    Asakura, Hidesaku
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [24] SARS-CoV-2 in the ocular surface of COVID-19 patients
    Xie, Hua-Tao
    Jiang, Shi-Yun
    Xu, Kang-Kang
    Liu, Xin
    Xu, Bing
    Wang, Lin
    Zhang, Ming-Chang
    EYE AND VISION, 2020, 7 (01)
  • [25] SARS-CoV-2 in the ocular surface of COVID-19 patients
    Hua-Tao Xie
    Shi-Yun Jiang
    Kang-Kang Xu
    Xin Liu
    Bing Xu
    Lin Wang
    Ming-Chang Zhang
    Eye and Vision, 7
  • [26] Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19
    Getu, Sisay
    Tiruneh, Tegenaw
    Andualem, Henok
    Hailemichael, Wasihun
    Kiros, Teklehayimanot
    Belay, Demeke Mesfin
    Kiros, Mulugeta
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 635 - 643
  • [27] Detecting SARS-CoV-2 in the Breath of COVID-19 Patients
    Li, Xiaoguang
    Li, Jing
    Ge, Qinggang
    Du, Yuguang
    Li, Guoqiang
    Li, Wei
    Zhang, Tong
    Tan, Lei
    Zhang, Runqiang
    Yuan, Xiaoning
    Zhang, He
    Zhang, Chen
    Liu, Wenjun
    Ding, Wei
    Sun, Liang
    Chen, Ke
    Wang, Zhuo
    Shen, Ning
    Lu, Jun
    FRONTIERS IN MEDICINE, 2021, 8
  • [28] Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients
    Huang, Y. Hanna
    Huang, Jong T.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4370 - 4373
  • [29] Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: A multicenter Italian experience
    Loffi, Marco
    Regazzoni, Valentina
    Toselli, Marco
    Cereda, Alberto
    Palmisano, Anna
    Vignale, Davide
    Moroni, Francesco
    Pontone, Gianluca
    Andreini, Daniele
    Mancini, Elisabetta Maria
    Monello, Alberto
    Iannopollo, Gianmarco
    Casella, Gianni
    Monetti, Francesco
    Monti, Lorenzo
    Ferrillo, Giuseppe
    Liccardo, Gaetano
    Tonet, Elisabetta
    Zucchetti, Ottavio
    Cossu, Alberto
    Dugo, Marco
    Patelli, Gianluigi
    Sergio, Pietro
    Esposito, Antonio
    Colombo, Antonio
    Giannini, Francesco
    Piccolo, Raffaele
    Danzi, Gian Battista
    PLOS ONE, 2021, 16 (01):
  • [30] Utility of probability scores for the diagnosis of pulmonary embolism in patients with SARS-CoV-2 infection: A systematic review
    Franco-Moreno, A. I.
    Bustamante-Fermosel, A.
    Ruiz-Giardin, J. M.
    Munoz-Rivas, N.
    Torres-Macho, J.
    Brown-Lavalle, D.
    REVISTA CLINICA ESPANOLA, 2023, 223 (01): : 40 - 49